Found "Medical Procedures": 272 results
Final Report: Coordinated Procurement: Lessons Learned Globally, Potential ASEAN Applications, and Implications for Antibiotic Access and Policy
This report examines global experiences in coordinated procurement of health technologies and explores their potential application for antibiotics in ASEAN. Drawing on a scoping review and stakeholder consultations, it analyses key determinants—including governance, financing, regulatory systems, an
Developing an Evidence Guide to Strengthen Public Investment Decisions for Digital Health Technologies in Low- and Middle-Income Countries
Digital health technologies (e.g., wearables, electronic health records, and artificial intelligence tools) are increasingly recognized for their potential to enhance care quality, efficiency, and reach of healthcare services while potentially reducing costs [1]. Landscape reviews have shown increasing investments by governments and other stakehold
Shiela Marie Selisana, PhD
Shiela is an Associate at the HITAP International Unit. She holds a doctoral degree in Microbiology and currently leads antimicrobial resistance (AMR)-related projects at HITAP, in collaboration with international partners such as the University of Oxford, City St George’s University of London, and global organizations including the World Health Or
Examining coordinated procurement mechanisms and related regulatory policies for healthcare products in ASEAN: case studies and lesson learned
Achieving universal access to essential healthcare products remains a critical challenge across low- and middle-income countries (LMICs). While individual countries may have made notable strides in strengthening their procurement and regulatory systems, regional disparities in access, affordability,
Case study of the real-time monitoring system of Thai Traditional and Alternative Medical (TTM) Services in Thailand
Traditional and complementary medicines (T&CM) have increased in uptake and economic importance globally. T&CM involves the examination, diagnosis, therapy, treatment, disease prevention, and rehabilitation. The World Health Organization\'s (WHO) Traditional Medicine Strategy 2014-2023 outlines a framework for action through the regulation,
Priority setting for health innovation and Early Health Technology Assessment for supporting research and development of medical innovation in Thailand (Fiscal year 2026)
68136067MU028L0medical innovation,health technology assessment,health economic evaluation,target product profiles,research and development
PMAC 2026: HITAP highlighted innovations and launched global projects and journals, reflecting the power of evidence at both community and international levels.
In the Prince Mahidol Award Conference 2026 (PMAC 2026), held from January 26–31, 2026, at the Centara Grand & Bangkok Convention Centre at CentralWorld, the Health Intervention and Technology Assessment Program Foundation (HITAP) participated in supporting and driving the international exchange
Preliminary recommendations on the establishment of a regional centre for infectious disease control in ASEAN
“United we stand, divided we fall” is a Thai idiom used to exemplify the importance of staying united and of teamwork and common interests. This idiom is reaffirmed in the context of the COVID-19 pandemic, shown in the global nature of catastrophe and the shared prospects of recovery. However, p
The developmental evaluation for seamless healthcare services through “One ID card smart hospital” policy
The policy \\\\\\\" One ID card smart hospital\\\\\\\" is a government policy from the Ministry of Public Health\\\\\\\'s Strategic Plan for Digital Health in 2024, addressing point 10 regarding digital health. Its objective is to elevate healthcare services by establishing data linkage across all levels and affiliations of public healthcare units.
Trends and predictors of caesarean section in Thailand before and during the COVID-19 pandemic: a retrospective analysis of national hospitalisation data under the Universal Coverage Scheme
Abstract
Objectives: Since 1985, the international healthcare community has recommended the ideal rate of caesarean section (CS) to be 10%–15% at the national level. The literature has reported that overused CS without necessary medical indications can be harmful to both maternal and chil
10 / Page